Company Valuation: Proteomics International Laboratories Ltd

Data adjusted to current consolidation scope
Fiscal Period: June 2021 2022 2023 2024 2025 2026
Market Cap 1 97.32 98.31 104 115.2 53.14 19
Change - 1.02% 5.83% 10.71% -53.86% -64.26%
Enterprise Value (EV) 1 91.78 96.19 98.08 108.9 42.39 15.83
Change - 4.81% 1.96% 10.99% -61.06% -62.66%
P/E -32.9x -19.7x -16.2x -17.4x -5.38x -2.21x
PBR 12.8x 29x 12.4x 12.2x 4.04x 3.52x
PEG - -0.3x -1.3x 3.89x -0.3x 0.2x
Capitalization / Revenue 35.6x 28.7x 32.7x 35.2x 16x 5.26x
EV / Revenue 33.5x 28x 30.8x 33.2x 12.8x 4.38x
EV / EBITDA -33.1x -20.8x -16.8x -17.8x -5.44x -2.04x
EV / EBIT -29.8x -19.3x -15.4x -16.2x -5.13x -1.85x
EV / FCF -72.6x -52.3x -19.5x -30.1x -12.8x -2.76x
FCF Yield -1.38% -1.91% -5.12% -3.32% -7.8% -36.2%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0281 -0.0471 -0.053 -0.0507 -0.0604 -0.0521
Distribution rate - - - - - -
Net sales 1 2.736 3.43 3.181 3.276 3.312 3.614
EBITDA 1 -2.774 -4.624 -5.836 -6.114 -7.791 -7.742
EBIT 1 -3.083 -4.977 -6.366 -6.741 -8.267 -8.552
Net income 1 -2.86 -4.973 -6.177 -6.376 -8.115 -8.56
Net Debt 1 -5.536 -2.112 -5.963 -6.324 -10.76 -3.169
Reference price 2 0.9250 0.9300 0.8600 0.8800 0.3250 0.1150
Nbr of stocks (in thousands) 105,206 105,706 120,979 130,893 163,521 165,184
Announcement Date 8/30/21 8/30/22 8/21/23 8/22/24 8/26/25 8/31/26
1AUD in Million2AUD
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
20.25x7.04x14.2x1.45% 67.98B
36.9x9.64x29.44x0.04% 64.94B
-77.3x14.92x-71.95x-.--% 27.58B
29.69x6.35x16.48x-.--% 25.74B
-15.85x6.12x-7.7x-.--% 26.06B
27.41x5.13x17.06x-.--% 20.09B
49.41x18.23x36.98x0.31% 17.16B
1289.22x37.23x812.54x-.--% 14.92B
18.23x5.44x12.69x-.--% 14.62B
Average 153.11x 12.23x 95.53x 0.2% 31.01B
Weighted average by Cap. 82.01x 10.35x 51.60x 0.38%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. PIQ Stock
  4. PIQLF Stock
  5. Valuation Proteomics International Laboratories Ltd